Medication abortion providers reported a surge in requests for and purchases of the drugs in the hours after President-elect ...

Ann-Hunter Van Kirk, Bloomberg Intelligence Senior Biopharmaceutical Analyst and co-author of the report, noted that improved ...

Orthopedic Imaging Equipment Market. The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 billion in 2021 and is forecast to reach US$ 14.6 billion by 2031, expand ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2024. "I'm honored to join ...

William Halsted, Johns Hopkins: Building off of the work of surgeons including Le Cat, Halsted developed the radical ... The drug, first launched in the UK in 1973 and approved by the Food and Drug ...

Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...

Instead, they’re left wondering how their pets ended up hurt or dead, after getting a shot that was supposed to give them new ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.